Embolic Protection Systems Market Size (2024 - 2029)

The embolic protection systems market is anticipated to experience significant growth over the forecast period, driven by an increase in neurovascular and cardiac complications and a rising demand for minimally invasive surgeries. The market's expansion is further supported by technological advancements and the growing prevalence of cardiovascular and neurovascular diseases, which enhance the need for these systems. Despite the positive outlook, challenges such as stringent regulatory environments, unfavorable government policies, and a shortage of skilled professionals may hinder market growth.

Market Size of Embolic Protection Systems Industry

Embolic Protection Systems Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 8.60 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Embolic Protection Systems Market Major Players

*Disclaimer: Major Players sorted in no particular order

Embolic Protection Systems Market Analysis

The embolic protection systems market studied was projected to grow with a CAGR of 8.6% over the forecast period.

COVID-19 had a significant impact on the embolic protection systems market since many neurovascular and cardiovascular surgeries were delayed or canceled during the initial wave of the pandemic. For instance, as per the article from PubMed published in February 2021, since neurological patients require more frequent hospitalization and had a higher chance of disability after discharge, patients had trouble getting regular monitoring, surgery, or treatment for their neurological issues because of the global lockdown, which had a significant impact on the market under study. Currently, the market is gaining its pre-pandemic environment due to the high demand for embolic protection systems as COVID-19-related restrictions have been eased. Also, the market is expected to witness growth in the coming years due to the rise in neurovascular and cardiac complications and an increase in the adoption of embolic protection systems.

Factors such as the rise in the prevalence of cardiovascular and neurovascular diseases and increasing demand for minimally invasive surgeries are expected to bolster market growth over the forecast period.

The major factor attributing to the growth of the market is the rising prevalence of cardiovascular and neurovascular diseases. For instance, as per the Global Stroke Fact Sheet 2022, around 12,224,551 cases of ischemic stroke were reported in 2022 across the globe. The same source further stated that over 12.2 million new strokes occur annually/each year globally. One in four people over age 25 will have a stroke in their lifetime. Since embolic protection systems are largely preferred in managing ischemic stroke, increasing cases of ischemic stroke are believed to propel the demand for these systems. Hence, the rise in cases of ischemic stroke is anticipated to utilize the embolic protection systems for the treatment and thereby boosting the market growth.

Furthermore, rising demand for minimally invasive procedures and increasing technological advancements are expected to boost the market growth. For instance, as per the article published in May 2022, in Frontiers, minimally invasive surgical (MIS) evacuation of the hematoma showed promising results and is likely to be implemented in clinical practice. Also, minimally invasive surgery (MIS) has proven to reduce mortality in deep-seated primary hematomas. Thus, chance of redcution in mortality for hematoms are expected to increase the adoption of minimally invasive surgeries and thereby likely to increase the demand for embolic protection systems and driving market growth.

Hence, due to the rise in cardiac and neurovascular complications, and the increase in the adoption of minimally invasive surgeries, the studied market is expected to witness significant growth over the forecast period. However stringent regulatory scenarios and unfavorable government policies and a lack of skilled professionals are the major drawbacks to market growth.

Embolic Protection Systems Industry Segmentation

As per the scope of the report, embolic protection devices (EPDs) prevent or reduce plaque debris from reaching the distal bed and thereby have the potential to reduce adverse clinical events. The Embolic Protection Systems Market is Segmented by Product Technology Type (Distal Occlusion Devices, Distal Filters, Proximal Occlusion Devices), Material (Nitinol, Polyurethane), Application (Neurovascular Diseases, Cardiovascular diseases, Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Technology Type
Distal Occlusion Devices
Distal Filters
Proximal Occlusion Devices
By Material
Nitinol
Polyurethane
By Application
Neurovascular Diseases
Cardiovascular diseases
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Embolic Protection Systems Market Size Summary

The embolic protection systems market is poised for significant growth, driven by the increasing prevalence of cardiovascular and neurovascular diseases and the rising demand for minimally invasive surgeries. The market, which experienced a setback due to the COVID-19 pandemic as many related surgeries were postponed, is now recovering as restrictions ease and the demand for these systems rises. The growing incidence of ischemic strokes, which necessitate the use of embolic protection systems, is a key factor propelling market expansion. Additionally, technological advancements and the adoption of minimally invasive procedures are expected to further boost market growth. However, challenges such as stringent regulatory environments and a shortage of skilled professionals may hinder progress.

North America is anticipated to maintain a significant share of the embolic protection systems market, supported by a high prevalence of cardiac and neurological conditions, increased healthcare spending, and the presence of major industry players. The region's market growth is further bolstered by research funding and clinical studies focused on embolic protection systems. The competitive landscape is characterized by key players like Boston Scientific Corporation, Abbott, and Medtronic, who are actively engaged in product development and innovation. These dynamics, coupled with the ongoing clinical research and advancements in embolic protection technologies, are expected to drive the market's growth trajectory over the forecast period.

Explore More

Embolic Protection Systems Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rise in Prevalence of Cardiovascular and Neurovascular Diseases

      2. 1.2.2 Increasing Demand for Minimally Invasive Surgeries

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Scenarios and Unfavorable Government Policies

      2. 1.3.2 Lack of Skilled Labor

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product Technology Type

      1. 2.1.1 Distal Occlusion Devices

      2. 2.1.2 Distal Filters

      3. 2.1.3 Proximal Occlusion Devices

    2. 2.2 By Material

      1. 2.2.1 Nitinol

      2. 2.2.2 Polyurethane

    3. 2.3 By Application

      1. 2.3.1 Neurovascular Diseases

      2. 2.3.2 Cardiovascular diseases

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Embolic Protection Systems Market Size FAQs

The Embolic Protection Systems Market is projected to register a CAGR of 8.60% during the forecast period (2024-2029)

Boston Scientific Corporation , Medtronic Plc, Abbott Laboratories, Cardinal Health and Hellman & Friedman LLC (Cordis) are the major companies operating in the Embolic Protection Systems Market.

Embolic Protection Systems Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)